Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Pharmaceutical Research
|
June 1, 1993
Disposition characteristics of protein drugs in the perfused rat kidney
K Mihara, T Hojo, M Fujikawa, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 24, 2001
Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer
N Maass, T Hojo, M Zhang, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
January 1, 1992
[The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer]
K Sawaguchi, T Hojo, S Nozaki, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1993
Disposition characteristics of model macromolecules in the perfused rat kidney
K Mihara, M Mori, T Hojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Expression of the tumor suppressor gene Maspin in human pancreatic cancers
N Maass, T Hojo, M Ueding, et al.
Acta Neuropathologica
|
January 1, 1995
Smaller axon and unaltered numbers of microtubules per axon in relation to number of myelin lamellae of myelinated fibers in the mutant quail deficient in neurofilaments
J X Zhao, A Ohnishi, C Itakura, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
July 1, 1994
[Laparoscopic extirpation of ovarian tumor: a trial to prevent spilling of tumor contents]
H Ishikawa, M Ito, M Goto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 23, 2001
Development of a new drug delivery system for protein drugs using silicone (II)
M Kajihara, T Sugie, T Hojo, et al.
Cancer Letters
|
August 4, 2001
Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues
T Hojo, Y Akiyama, K Nagasaki, et al.
British Journal of Cancer
|
August 4, 2011
Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
T Hasebe, M Iwasaki, S Akashi-Tanaka, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Pharmaceutical Research
|
June 1, 1993
Disposition characteristics of protein drugs in the perfused rat kidney
K Mihara, T Hojo, M Fujikawa, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 24, 2001
Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer
N Maass, T Hojo, M Zhang, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
January 1, 1992
[The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer]
K Sawaguchi, T Hojo, S Nozaki, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1993
Disposition characteristics of model macromolecules in the perfused rat kidney
K Mihara, M Mori, T Hojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Expression of the tumor suppressor gene Maspin in human pancreatic cancers
N Maass, T Hojo, M Ueding, et al.
Acta Neuropathologica
|
January 1, 1995
Smaller axon and unaltered numbers of microtubules per axon in relation to number of myelin lamellae of myelinated fibers in the mutant quail deficient in neurofilaments
J X Zhao, A Ohnishi, C Itakura, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
July 1, 1994
[Laparoscopic extirpation of ovarian tumor: a trial to prevent spilling of tumor contents]
H Ishikawa, M Ito, M Goto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 23, 2001
Development of a new drug delivery system for protein drugs using silicone (II)
M Kajihara, T Sugie, T Hojo, et al.
Cancer Letters
|
August 4, 2001
Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues
T Hojo, Y Akiyama, K Nagasaki, et al.
British Journal of Cancer
|
August 4, 2011
Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
T Hasebe, M Iwasaki, S Akashi-Tanaka, et al.
Page
of 9